HAVCR2 and viral infectious disease: The new monoclonal antibody (L3G) against human Tim-3 increases STAT1 phosphorylation in both T cells and monocytes/macrophages and enhances IL-2 and type I interferon expression; in addition, L3G inhibited H1N1 viral infection in immune cells, as shown by Ge Li et al. [155].